| Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events K Otomo, T Atsumi, O Amengual, Y Fujieda, M Kato, K Oku, T Horita, ... Arthritis & Rheumatism 64 (2), 504-512, 2012 | 310 | 2012 |
| The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis T Kurita, S Yasuda, K Oba, T Odani, M Kono, K Otomo, Y Fujieda, K Oku, ... Rheumatology 54 (1), 39-44, 2015 | 159 | 2015 |
| Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors J Nestor, Y Arinuma, TS Huerta, C Kowal, E Nasiri, N Kello, Y Fujieda, ... Journal of Experimental Medicine 215 (10), 2554-2566, 2018 | 141 | 2018 |
| Antibodies as mediators of brain pathology L Brimberg, S Mader, Y Fujieda, Y Arinuma, C Kowal, BT Volpe, ... Trends in immunology 36 (11), 709-724, 2015 | 66 | 2015 |
| Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome Y Fujieda, T Atsumi, O Amengual, T Odani, K Otomo, M Kato, K Oku, ... Lupus 21 (14), 1506-1514, 2012 | 65 | 2012 |
| Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in Hepatitis B surface antigen-negative cases M Kato, T Atsumi, T Kurita, T Odani, Y Fujieda, K Otomo, T Horita, ... The Journal of rheumatology 38 (10), 2209-2214, 2011 | 58 | 2011 |
| Understanding the antibody repertoire in neuropsychiatric systemic lupus erythematosus and neuromyelitis optica spectrum disorder: do they share common targets? S Mader, V Jeganathan, Y Arinuma, Y Fujieda, I Dujmovic, J Drulovic, ... Arthritis & Rheumatology 70 (2), 277-286, 2018 | 57 | 2018 |
| Long-term outcome in Japanese patients with lupus nephritis M Kono, S Yasuda, M Kato, Y Kanetsuka, T Kurita, Y Fujieda, K Otomo, ... Lupus 23 (11), 1124-1132, 2014 | 56 | 2014 |
| Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study R Hisada, M Kato, E Sugawara, Y Fujieda, K Oku, T Bohgaki, O Amengual, ... Journal of thrombosis and haemostasis 15 (9), 1782-1787, 2017 | 55 | 2017 |
| First‐Line, Non‐Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti–β2‐Glycoprotein I Domain … H Nakamura, K Oku, O Amengual, K Ohmura, Y Fujieda, M Kato, ... Arthritis care & research 70 (4), 627-634, 2018 | 51 | 2018 |
| Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease T Odani, S Yasuda, Y Ota, Y Fujieda, Y Kon, T Horita, Y Kawaguchi, ... Rheumatology 51 (10), 1765-1774, 2012 | 44 | 2012 |
| The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review M Kato, H Kataoka, T Odani, Y Fujieda, K Otomo, K Oku, T Horita, ... Lupus 20 (10), 1047-1056, 2011 | 43 | 2011 |
| Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts E Sugawara, M Kato, Y Kudo, W Lee, R Hisada, Y Fujieda, K Oku, ... Autophagy 16 (5), 946-955, 2020 | 39 | 2020 |
| The Contribution of SAA1 Polymorphisms to Familial Mediterranean Fever Susceptibility in the Japanese Population K Migita, K Agematsu, J Masumoto, H Ida, S Honda, Y Jiuchi, Y Izumi, ... PLoS One 8 (2), e55227, 2013 | 37 | 2013 |
| Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming K Aso, M Kono, M Kanda, Y Kudo, K Sakiyama, R Hisada, K Karino, ... Nature communications 14 (1), 984, 2023 | 34 | 2023 |
| Diversity of neuropsychiatric manifestations in systemic lupus erythematosus Y Fujieda Immunological medicine 43 (4), 135-141, 2020 | 30 | 2020 |
| Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation RYO Hisada, M Kato, ERI Sugawara, M Kanda, Y Fujieda, K Oku, ... Journal of thrombosis and haemostasis 17 (7), 1134-1143, 2019 | 30 | 2019 |
| Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome N Ohnishi, Y Fujieda, R Hisada, H Nakamura, M Kato, K Oku, T Bohgaki, ... Rheumatology 58 (6), 969-974, 2019 | 30 | 2019 |
| Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus Y Fujieda, H Kataoka, T Odani, K Otomo, M Kato, S Fukaya, K Oku, ... Modern rheumatology 21 (3), 276-281, 2011 | 30 | 2011 |
| Impact of weekly teriparatide on the bone and mineral metabolism in hemodialysis patients with relatively low serum parathyroid hormone: a pilot study J Yamamoto, D Nakazawa, S Nishio, Y Ishikawa, M Makita, Y Kusunoki, ... Therapeutic Apheresis and Dialysis 24 (2), 146-153, 2020 | 28 | 2020 |
